SecSonar.com

60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

60 Degrees Pharmaceuticals, Inc. (SXTP) is a Biotechnology company based in US with a market capitalization of $1.2M. Revenue grew 65.5% year-over-year and free cash flow was negative at -$7.1M. This page tracks SXTP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3 employees · IPO Jul 12, 2023

Valuation

Valuation & price

$1.39 · as of May 17, 2026 · -86.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.35

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.08$5.73$1.38Jul 25Dec 25Jul 26Jul 7, 25$9.32Jul 9, 25$9.84Jul 11, 25$10.08Jul 15, 25$7.00Jul 17, 25$6.04Jul 21, 25$5.56Jul 23, 25$5.36Jul 25, 25$5.24Jul 29, 25$5.32Jul 31, 25$5.36Aug 4, 25$5.36Aug 6, 25$5.40Aug 11, 25$5.52Aug 13, 25$5.40Aug 15, 25$5.28Aug 19, 25$5.12Aug 21, 25$5.20Aug 25, 25$5.16Aug 27, 25$4.96Aug 29, 25$5.64Sep 3, 25$5.84Sep 5, 25$5.64Sep 9, 25$5.68Sep 11, 25$5.68Sep 16, 25$5.76Sep 18, 25$5.84Sep 22, 25$5.52Sep 24, 25$5.56Sep 26, 25$5.44Sep 30, 25$5.92Oct 2, 25$5.72Oct 6, 25$5.92Oct 8, 25$6.20Oct 10, 25$6.24Oct 14, 25$7.20Oct 16, 25$6.00Oct 21, 25$5.84Oct 23, 25$5.80Oct 27, 25$5.92Oct 29, 25$5.60Oct 31, 25$5.44Nov 4, 25$5.04Nov 6, 25$5.20Nov 10, 25$5.12Nov 12, 25$4.92Nov 14, 25$3.64Nov 18, 25$4.12Nov 20, 25$4.04Nov 25, 25$4.12Nov 28, 25$4.24Dec 2, 25$3.96Dec 4, 25$3.92Dec 8, 25$3.92Dec 10, 25$3.76Dec 12, 25$3.41Dec 16, 25$3.32Dec 18, 25$3.36Dec 22, 25$3.15Dec 24, 25$2.76Dec 29, 25$2.21Jan 2, 26$2.06Jan 6, 26$2.06Jan 8, 26$2.05Jan 12, 26$2.28Jan 14, 26$1.91Jan 16, 26$2.44Jan 21, 26$2.00Jan 23, 26$4.54Jan 27, 26$4.82Jan 29, 26$4.84Feb 2, 26$3.64Feb 4, 26$4.38Feb 9, 26$4.11Feb 11, 26$3.95Feb 13, 26$3.51Feb 18, 26$3.09Feb 20, 26$3.06Feb 24, 26$3.06Feb 26, 26$2.96Mar 2, 26$3.04Mar 4, 26$2.27Mar 6, 26$2.05Mar 10, 26$1.88Mar 12, 26$2.91Mar 17, 26$2.25Mar 19, 26$1.93Mar 23, 26$1.83Mar 25, 26$1.55Mar 27, 26$1.50Mar 31, 26$1.75Apr 2, 26$1.86Apr 7, 26$1.77Apr 9, 26$1.74Apr 13, 26$1.94Apr 15, 26$1.96Apr 17, 26$1.78Apr 22, 26$1.80Apr 24, 26$1.63Apr 28, 26$1.60Apr 30, 26$1.58May 4, 26$1.61May 6, 26$1.66May 8, 26$1.54May 12, 26$1.50May 14, 26$1.46May 18, 26$1.44May 20, 26$1.40May 22, 26$1.48May 28, 26$1.49Jun 1, 26$1.46Jun 3, 26$1.45Jun 5, 26$1.42Jun 9, 26$1.39Jun 11, 26$1.38Jun 15, 26$1.49Jun 17, 26$1.62Jun 22, 26$1.69Jun 24, 26$1.69Jun 26, 26$1.61Jul 2, 26$1.74
$1.3652-week range$10.44
Loading valuation history…

Fundamentals

Key fundamentals

$1.2M

Market cap

65.5%

Revenue growth (YoY)

22.3%

Gross margin

-$7.1M

Free cash flow (USD)

-$2.6M

Net debt

Net cash position

489.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$2.2MFY 2021$1.2MFY 2022$223.2KFY 2023$253.6KFY 2024$607.6KFY 2025$1.0M
$2.2M$1M

Free cash flow by year

2020 → 2025

FY 2020$-238.3KFY 2021$-684.5KFY 2022$-1.1MFY 2023$-4.7MFY 2024$-5.8MFY 2025$-7.1M
-$238.3K-$7.1M

Gross margin by year

2021 → 2025

FY 202126.7%FY 2022-93.7%FY 2023-87.2%FY 202436.7%FY 202522.3%
26.7%22.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-1.28)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $10KDOW GEOFFREY S · Director, President and CEO · $10.1KJun 15, 2026Filing
  • 8-K eventRegulatory Application PlannedJun 3, 2026Filing
  • 8-K eventDirector AppointmentMay 18, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing

Questions

Frequently asked questions

What is 60 Degrees Pharmaceuticals, Inc.'s market cap?

60 Degrees Pharmaceuticals, Inc. (SXTP) has a market capitalization of $1.2M.

What is SXTP's P/E ratio?

A meaningful P/E ratio is not available for SXTP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SXTP's price-to-book (P/B) ratio?

SXTP trades at 0.35 times book value per share.

When did 60 Degrees Pharmaceuticals, Inc. last report earnings?

SXTP last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying SXTP stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at 60 Degrees Pharmaceuticals, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

AIM

AIM ImmunoTech Inc.

$1.3M

NEXR

Nexera Technologies Ltd

$1M

VRAX

Virax Biolabs Group Limited

$769K

ASBP

Aspire Biopharma Holdings, Inc.

$627.6K

SCNI

Scinai Immunotherapeutics Ltd.

$604.8K

CANF

Can-Fite BioPharma Ltd.

$1.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.